We are monitoring the impact of COVID-19 on MEA Antifungal Drugs Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2019
ID: 217
Share on
Share on

Middle East & Africa Antifungal Drugs Market Research Report – Segmented By Drug Type, Therapeutic Indications, Application, Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis, Size, Share, Growth, Trends, Forecast | 2019 – 2024

Pulished: August, 2019
ID: 217
Pages: 145

MEA Antifungal Drugs Market Size & Growth (2019 - 2024)

As per the report published, the size of the Antifungal Drugs Market in the Middle East and Africa was worth USD 1.04 billion in 2019 and estimated to be growing at a CAGR of 3.462%, to reach USD 1.24 billion by 2024. In the next few years, the market is expected to grow enormously with the growing global population.

Antifungal drugs are used commonly for curing fungal infections occurring due to, unclean, unhygienic and damp environment. Invasion of epithelial tissue by microscopic organisms lead to fungal infections. Systemic fungal infections are those caused due to indigestion or inhalation of spores, leading to fungal pneumonia and diseases like candidaisis, meningitis, mucormycosis, etc. are caused by opportunistic fungus. Although majority of the fungal infections and diseases are commonly non-lethal, they are very uncomforting to the host and their common occurrence is responsible for the rising antifungal drugs market. Antifungal drugs work via various mechanisms such as by inhibiting of cell wall formation, cell membrane disruption and cell division.

The major factors that are driving the market are increasing awareness of fungal infections with the growing incidence rate of antifungal infections all over the world, increasing government and corporate funds in the industry. And also the development of public private partnership in the pharmaceutical industry, the rising popularity of over-the-counter antifungal drugs for dermal infections are vastly responsible for the growing antifungal drugs market size. Also, the rising population having weak immune system, in whom the occurrence of fungal infections is much more than average, will drive the market. High prevalence of conventional drugs used for the treatment of fungal infections is significantly restraining the market growth.

Cost of drugs and their effectiveness in treatments remain as the challenges for the market

This research report segmented and sub-segmented into the following categories:

  • By Drug Type: Echinocandins, Azoles, Polyenes, Allylamines and Others
  • By Therapeutic Indications: Aspergillosis, Dermatophytosis, Candidiasis and Others
  • By Application: Powders, Ointments, Drugs and Pastes
  • By Country: KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA

Geographically, Middle East commands major share in the region and Africa is the fastest growing region. Growing awareness of antifungal drugs is the major driver of the market in the region.

Top companies operating in the MEA Antifungal Drugs Market profiled in the report are Alternaria, Pfizer, Novartis, Sanofi-Aventis, Merck & Co., Asperqillus, Kramer Laboratories, Bayer Healthcare, Enzon Pharmaceuticals, Glaxosmithkline Gilead and Abbott Laboratories.

1. Introduction                 

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods          

                1.4 General Study Assumptions

2. Research Methodology                           

                2.1 Introduction               

                2.2 Research Phases      

                                2.2.1 Secondary Research

                                2.2.2 Primary Research

                                2.2.3 Econometric Modelling

                                2.2.4 Expert Validation

                2.3 Analysis Design         

                2.4 Study Timeline          

3. Overview                       

                3.1 Executive Summary

                3.2 Key Inferences         

                3.3 New Developments               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                    

                4.1 Market Drivers          

                4.2 Market Restraints    

                4.3 Key Challenges         

                4.4 Current Opportunities in the Market              

5. Market Segmentation                              

                5.1 By Drug Type             

                                5.1.1 Echinocandins

                                5.1.2 Azoles

                                5.1.3 Polyenes

                                5.1.4 Allylamines

                                5.1.5 Others

                5.2 By Therapeutic Indications   

                                5.2.1 Aspergillosis

                                5.2.2 Dermatophytosis

                                5.2.3 Candidiasis

                                5.2.4 Others

                5.3 By Application           

                                5.3.1 Powders

                                5.3.2 Ointments

                                5.3.5 Drugs

                                5.3.4 Pastes

6. Geographical Analysis                              

                6.1 Introduction               

                6.2 Middle-East                

                6.3 Africa            

7. Strategic Analysis                       

                7.1 PESTLE analysis         

                                7.1.1 Political

                                7.1.2 Economic

                                7.1.3 Social

                                7.1.4 Technological

                                7.1.5 Legal

                                7.1.6 Environmental

                7.2 Porter’s Five analysis              

                                7.2.1 Bargaining Power of Suppliers

                                7.2.2 Bargaining Power of Consumers

                                7.2.3 Threat of New Entrants

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry

8. Market Leaders' Analysis                        

                8.1 Alternaria    

                                8.1.1 Overview

                                8.1.2 Product Analysis

                                8.1.3 Strategic Evaluation and Operations

                                8.1.4 Financial analysis

                                8.1.5 Legal issues

                                8.1.6 Recent Developments

                                8.1.7 SWOT analysis

                                8.1.8 Analyst View

                8.2 Pfizer            

                8.3 Novartis       

                8.4 Sanofi-Aventis          

                8.5 Merck & Co.               

                8.6 Asperqillus  

                8.7 Kramer Laboratories               

                8.8 Bayer Healthcare     

                8.9 Enzon Pharmaceuticals          

                8.10 Glaxosmithkline Gilead       

                8.11 Abbott Laboratories             

9. Competitive Landscape                           

                9.1 Market share analysis            

                9.2 Merger and Acquisition Analysis       

                9.3 Agreements, collaborations and Joint Ventures         

                9.4 New Product Launches         

10. Expert Opinions                        

                10.1 Market Outlook     

                10.2 Investment Opportunities 

Appendix                           

                a) List of Tables

                b) List of Figures              

  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Middle East & Africa Antifungal Drugs Market By Region, From 2019 - 2024(USD Million)
  2. Middle East & Africa Antifungal Drugs Market By Drug Type, From 2019 - 2024(USD Million)
  3. Middle East & Africa Echinocandins Market By Region, From 2019 - 2024(USD Million)
  4. Middle East & Africa Azoles Market By Region, From 2019 - 2024(USD Million)
  5. Middle East & Africa Polyenes Market By Region, From 2019 - 2024(USD Million)
  6. Middle East & Africa Allylamines Market By Region, From 2019 - 2024(USD Million)
  7. Middle East & Africa Other Drugs Market By Region, From 2019 - 2024(USD Million)
  8. Middle East & Africa Antifungal Drugs Market By Therapeutic Indications, From 2019 - 2024(USD Million)
  9. Middle East & Africa Aspergillosis Market By Region, From 2019 - 2024(USD Million)
  10. Middle East & Africa Dermatophytosis Market By Region, From 2019 - 2024(USD Million)
  11. Middle East & Africa Candidiasis Market By Region, From 2019 - 2024(USD Million)
  12. Middle East & Africa Other Therapeutic Indications Market By Region, From 2019 - 2024(USD Million)
  13. Middle East & Africa Antifungal Drugs Market By Application, From 2019 - 2024(USD Million)
  14. Middle East & Africa Powders Market By Region, From 2019 - 2024(USD Million)
  15. Middle East & Africa Ointments Market By Region, From 2019 - 2024(USD Million)
  16. Middle East & Africa Drugs Market By Region, From 2019 - 2024(USD Million)
  17. Middle East & Africa Pastes Market By Region, From 2019 - 2024(USD Million)
  18. Middle East Antifungal Drugs Market By Drug Type, From 2019 - 2024(USD Million)
  19. Middle East Antifungal Drugs Market By Therapeutic Indications, From 2019 - 2024(USD Million)
  20. Middle East Antifungal Drugs Market By Application, From 2019 - 2024(USD Million)
  21. Africa Antifungal Drugs Market By Drug Type, From 2019 - 2024(USD Million)
  22. Africa Antifungal Drugs Market By Therapeutic Indications, From 2019 - 2024(USD Million)
  23. Africa Antifungal Drugs Market By Application, From 2019 - 2024(USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample